The Contribution of Cement Companies to the Achievement of Sustainable Development Goals and its Effect in Building Trust in their Communities

Companies have reoriented their actions in contributing towards the attainment of the Sustainable Development Goals (SDGs). The SDGs enhances the reputation of enterprises and builds confidence in their stakeholders. People's confidence toward the company generates favorable attitudes and behaviors. Therefore, the purpose of this paper is to identify the level of contribution of cement companies to achieve Sustainable Development Goals and its effect on the trust of its local communities. In achieving the purpose of this work, we study the perception of people about the actions that the company makes in favor of sustainable development. The study variables correspond to 9 of 17 SDGs classified into two categories (people and environment). The nine variables are compared with confidence. Data are also analyzed with statistical standardization and chi-square tools. The results show that only 40% of the actions carried out by the company contribute to the achievement of the SDGs. However, there is no significant relationship between the population's confidence in the company and the actions that the firm makes in favor of sustainable development

Incorporación De La Sustentabilidad En El Modelo De Negocio De Las Empresas Más Grandes De La Industria Del Cemento En México A Través De La Gestión Estratégica

In order to operationalize the concept of sustainability in the business world, organizations have to transform their mission, align the design of the complete business system and innovate their business model (Markevich, 2009). In this sense, the purpose of the work is to study the way in which two companies in the cement industry in Mexico incorporate sustainability in the strategic management of their business model. The study was carried out through the content analysis of the sustainability reports of the companies between 2015 and 2017. The results show that sustainability is incorporated through the elements included in the four stages of the business model and in all the hierarchical levels of the companies. However, there is no balanced orientation towards the three dimensions of sustainability in both companies

Latin American study of hereditary breast and ovarian cancer LACAM : a genomic epidemiology approach

Q2Q1Artículo original1-13Purpose: Hereditary Breast and Ovarian Cancer (HBOC) syndrome is responsible for ~5–10% of all diagnosed breast and ovarian cancers. Breast cancer is the most common malignancy and the leading cause of cancer-related mortality among women in Latin America (LA). The main objective of this study was to develop a comprehensive understanding of the genomic epidemiology of HBOC throughout the establishment of The Latin American consortium for HBOC-LACAM, consisting of specialists from 5 countries in LA and the description of the genomic results from the first phase of the study. Methods: We have recruited 403 individuals that fulfilled the criteria for HBOC from 11 health institutions of Argentina, Colombia, Guatemala, Mexico and Peru. A pilot cohort of 222 individuals was analyzed by NGS gene panels. One hundred forty-three genes were selected on the basis of their putative role in susceptibility to different hereditary cancers. Libraries were sequenced in MiSeq (Illumina, Inc.) and PGM (Ion Torrent-Thermo Fisher Scientific) platforms. Results: The overall prevalence of pathogenic variants was 17% (38/222); the distribution spanned 14 genes and varied by country. The highest relative prevalence of pathogenic variants was found in patients from Argentina (25%, 14/57), followed by Mexico (18%, 12/68), Guatemala (16%, 3/19), and Colombia (13%, 10/78). Pathogenic variants were found in BRCA1 (20%) and BRCA2 (29%) genes. Pathogenic variants were found in other 12 genes, including high and moderate risk genes such as MSH2, MSH6, MUTYH, and PALB2. Additional pathogenic variants were found in HBOC unrelated genes such as DCLRE1C, WRN, PDE11A, and PDGFB. Conclusion: In this first phase of the project, we recruited 403 individuals and evaluated the germline genetic alterations in an initial cohort of 222 patients among 4 countries. Our data show for the first time in LA the distribution of pathogenic variants in a broad set of cancer susceptibility genes in HBOC. Even though we used extended gene panels, there was still a high proportion of patients without any detectable pathogenic variant, which emphasizes the larger, unexplored genetic nature of the disease in these populations